Kappa Free Light Chains in MS and CIS
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at a protein called kappa free light chains (KFLC) in the spinal fluid and blood of people with multiple sclerosis (MS) or a first MS-like episode (CIS). The goal is to better understand how this protein relates to the disease, which may help with diagnosis and monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with multiple sclerosis (MS) or a first episode of MS-like symptoms (called clinically isolated syndrome or CIS).
- You must be between 18 and 70 years old.
- You must have had a lumbar puncture (spinal tap) and a blood draw, and the samples must be available for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks specific proteins in spinal fluid to see whether they can predict how multiple sclerosis (or related symptoms like optic neuritis) may go over time. It may help doctors better estimate prognosis using results from tests you may already be having.
This study looks at different immune cells in blood and, sometimes, spinal fluid (CSF) to understand what’s driving multiple sclerosis (MS) or early MS-like symptoms. Your participation may help researchers better explain the disease and potentially improve how it’s diagnosed or treated.
This study looks at a protein called FCRL5 in the blood of people with multiple sclerosis (MS), as well as healthy volunteers and people with Sjögren's syndrome. The goal is to understand how this protein relates to MS and how it might affect treatment response. If you have MS and are about to start a new treatment, you may be able to join.
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
This study follows people with multiple sclerosis (MS) or a related condition to learn how pregnancy affects MS. You may be asked to complete health questionnaires and get MRI scans, which can help researchers understand what changes during pregnancy.
This study looks at a blood marker called TWEAK to see if it can signal when multiple sclerosis or its first symptoms might flare up again. If you join, your blood would be checked at regular visits to help predict future inflammation.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.